Clovis Oncology
CLVS
$0.08120
Share price
0.00%
Change (1 day)
-95.08%
Change (1 year)
Categories
Clovis Oncology (CLVS) - Net assets
Net assets on the balance sheet as of September 2022 : -$0.42 B
According to Clovis Oncology's latest financial reports the company has -$0.42 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Clovis Oncology - Net assets on balance sheet (from 2010 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2021-12-31 | $-0.28 B | 75.65% |
| 2020-12-31 | $-0.16 B | -8.9% |
| 2019-12-31 | $-0.18 B | -218.97% |
| 2018-12-31 | $0.14 B | -60.16% |
| 2017-12-31 | $0.36 B | -10216.57% |
| 2016-12-31 | $-3.64 M | -101.21% |
| 2015-12-31 | $0.30 B | -9.34% |
| 2014-12-31 | $0.33 B | -33.39% |
| 2013-12-31 | $0.49 B | 272.96% |
| 2012-12-31 | $0.13 B | 1.29% |
| 2011-12-31 | $0.13 B | -340.72% |
| 2010-12-31 | $-54.75 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | -16,557.60% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | -21,466.59% | 🇺🇸 USA |
 AbbVie ABBV | $10.39 B | -2,588.00% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | -2,699.68% | 🇺🇸 USA |
 AstraZeneca AZN | $37.50 B | -9,073.98% | 🇬🇧 UK |
 BioMarin Pharmaceutical BMRN | $4.95 B | -1,284.90% | 🇺🇸 USA |